[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"ivWatch, LLC\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":59},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,39],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":14,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":38},"100616908",false,"NCT07311733","Milky Way Sensor: Device Validation for Infiltrated Tissues","Inclusion Criteria:\n\n* 18 years of age or older\n* Healthy, verified by an eligible designation on the Health History Form\n\nExclusion Criteria:\n\n* Abnormal bleeding \u002F hemophilia\n* Absence of sensation in one or both arms\n* Allergy to common medical materials\n* Blood clotting disorder\n* Currently enrolled in another clinical trial\n* Current hepatitis infection or any history of hepatitis B or C\n* Currently pregnant\n* Daily regimen of blood thinning medication (e.g., aspirin, ibuprofen, naproxen, Coumadin®\u002Fwarfarin, Eliquis®\u002Fapixaban).\n* Fever at the time of study visit (≥100.4°F)\n* Frequent dizziness or fainting spells, especially with needles\n* History of chronic, severe anemia\n* History of stroke\n* HIV \u002F Aids\n* Immune deficiency disorder\n* Lymphedema\n* Major surgery or scar tissue which would complicate PIV access\n* Needle phobia\n* Radiation \u002F chemotherapy in the last year\n* Received IV therapy in 14 days prior to study visit\n* Severe dehydration on day of study visit\n* Sick or had an infection in 14 days prior to study visit\n* Tattoo(s) that severely limits vein visualization at a sensor monitoring location\n* Unstable or uncontrolled cardiopulmonary disorder\n* Uncontrolled seizures",true,"ALL","18 Years",{"count":18,"type":19},28,"ESTIMATED","INTERVENTIONAL",[22],"NA","A single arm trial consisting of 28 adult volunteers to assess the safety and efficacy of ivWatch sensors when observing infiltrated tissues at common sites for peripheral IV therapy.",[25],"Infiltration of Peripheral IV Therapy","NOT_YET_RECRUITING","2025-12-29",{"date":29,"type":30},"2025-12-31","ACTUAL",{"date":32,"type":19},"2026-01",{"date":34,"type":19},"2026-02",{"name":36,"class":37},"ivWatch, LLC","INDUSTRY",1,{"id":40,"slug":4,"hasResults":10,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":4,"eligibilityCriteria":44,"healthyVolunteers":14,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":45,"targetDuration":4,"studyType":20,"phases":47,"briefSummary":48,"conditions":49,"keywords":50,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":58,"locationsCount":4},"100610502","NCT07228416","Milky Way Sensor Motion Validation","Milky Way Sensor: Device Validation for Non-Infiltrated Tissues","Inclusion Criteria:\n\n* 18 years of age or older\n* Healthy individual, verified by an eligible designation on the Health History Form\n\nExclusion Criteria:\n\n* Currently enrolled in another clinical trial\n* Currently pregnant or trying to become pregnant\n* Serious and uncontrolled medical condition\n* Tattoo(s), scarring, or bruising that severely limits vein visualization at a sensor monitoring location\n* Medical adhesive allergy\n* Sleepwalking occurrence in the last year\n* Current drug\u002Falcohol dependence\n* Sick or had an infection in the last 14 days\n* Hospitalized in the last 14 days\n* Fever at the time of study visit (≥100.4°F)",{"count":46,"type":19},25,[22],"A single arm study of 20 adult volunteers to assess the safety and efficacy of the ivWatch sensors when observing non-infiltrated (normal) tissues at common peripheral IV therapy sites.",[25],[51],"motion","2025-11-13",{"date":54,"type":30},"2025-11-14",{"date":56,"type":19},"2025-12",{"date":32,"type":19},{"name":36,"class":37},""]